ArticleBMJ open2025
Prevalence and risk factors of paediatric acute ischaemic stroke: a systematic review and meta-analysis protocol.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPaediatric acute ischaemic stroke (AIS) is a rare but severe neurological condition, often leading to long-term disability and considerable societal burden. Compared with adults, paediatric AIS exhibits distinct clinical characteristics and aetiologies, making early identification and prevention more challenging. This study aims to systematically review the prevalence and risk factors of paediatric AIS, providing a comprehensive evidence base for clinical prevention and management. METHODS AND ANALYSIS: A systematic search will be conducted across major databases, including PubMed, Embase, Web of Science and Cochrane Library, from inception to August 2025. We will include observational studies reporting on the prevalence or risk factors of paediatric AIS. Two independent reviewers will screen the literature, extract data and assess study quality using the Newcastle-Ottawa scale. Meta-analysis will be performed using RevMan 5.4 and StataMP 16.0. Heterogeneity will be evaluated using the I² statistic, and subgroup and sensitivity analyses will be conducted as needed. The Grading of Recommendations Assessment, Development and Evaluation system will be used to assess the quality of evidence. ETHICS AND DISSEMINATION: Because no patients were involved, ethical approval was not required. The final results of this research will be submitted to a peer-reviewed journal or presented at relevant conferences, and any deviations from this protocol will be recorded and explained in the final report. REGISTRATION: This study has been registered in the PROSPERO (PROSPERO Registration Number: CRD420251067538).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.